The cross-sectional and longitudinal relationship of diabetic retinopathy to cognitive impairment: a systematic review and meta-analysis
- PMID: 35501601
- PMCID: PMC9873601
- DOI: 10.1038/s41433-022-02033-2
The cross-sectional and longitudinal relationship of diabetic retinopathy to cognitive impairment: a systematic review and meta-analysis
Abstract
Objectives: To establish a potential relationship between diabetic retinopathy (DR) and different stages of cognitive impairment METHODS: Literature searches were conducted on PubMed and EMBASE, with keywords "diabetic retinopathy" and "cognitive impairment". Inclusion criteria were original human studies, and English language. Quality of studies was assessed by the Newcastle-Ottawa Quality Assessment (NOSGEN). The register number of this study on the International Prospective Register of Systematic Reviews (PROSPERO) is CRD42021236747. The main outcome measures were odds ratios (OR) and risk ratios (RR) for cross-sectional and longitudinal studies, respectively. Meta-regression was performed to evaluate the effects of potential moderator variables, including, age, onset age of diabetes mellitus (DM), duration of DM, and HbA1c.
Results: Twenty-five studies (17 cross-sectional and 8 longitudinal studies) with a total of 1,963,914 subjects, were included. Among the cross-sectional studies, the pooled ORs of any cognitive impairment, early stage of cognitive impairment and dementia in subjects with DR (95% confidence interval) were 1.48 (1.08-2.02), 1.59 (1.01-2.51), and 1.13 (0.86-1.50), respectively. Among the longitudinal studies, the pooled RRs of any cognitive impairment, early stage of cognitive impairment, and dementia in subjects with DR (95% confidence interval) were 1.35 (1.12-1.65), 1.50 (1.06-2.12), and 1.31 (1.03-1.66), respectively. Meta-regression showed age, onset age of DM, duration of DM, and glycated hemoglobin (HbA1c) were not statistically associated with the outcomes.
Conclusions: The presence of DR in DM patients indicates both higher odds of prevalent cognitive impairment and escalated risks of developing cognitive impairment in the future.
摘要: 目的: 建立糖尿病视网膜病变(DR)与不同阶段认知障碍之间的潜在关联。 方法: PubMde 和 EMBASE数据库中使用“糖尿病视网膜病变”和“认知障碍”两个关键词进行文献检索。纳入标准为临床研究和英文文献, 我们通过Newcastle-Ottawa质量评估(NOSGEN)方法评估研究质量。本研究在国际前瞻性系统性综述登记研究(PROSPERO)中的登记研究编号为CRD42021236747。比值比 (OR) 和风险比 (RR) 分别是横断面研究和纵向研究的主要结局指标。荟萃-回归分析用以评估潜在调节变量带来的影响, 包括年龄、糖尿病(DM)发病年龄、DM病程和HbA1c。 结果: 共纳入25项研究 (17项横断面研究和8项纵向研究), 一共1, 963, 914例受试对象。在横断面研究中, DR受试者中任何认知障碍、早期认知障碍及痴呆的合并OR (95%置信区间) 分别为1.48(1.08–2.02)、1.59(1.01–2.51)和1.13(0.86–1.50)。在纵向研究中, DR受试者中任何认知障碍、早期认知障碍及痴呆的合并RR (95%置信区间) 分别为 1.35 (1.12–1.65), 1.50 (1.06–2.12) and 1.31 (1.03–1.66)。荟萃-回归分析显示, 年龄, DM发病年龄, DM病程和糖化血红蛋白 (HbA1c) 与认知障碍结局无统计学相关性。 结论: 并发DR的DM患者发生认知障碍的几率高, 且将来发生认知障碍的风险也高。.
© 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Conflict of interest statement
The authors declare no competing interests.
Figures








Similar articles
-
Systematic review on urine albumin testing for early detection of diabetic complications.Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300. Health Technol Assess. 2005. PMID: 16095545
-
Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis.J Glob Health. 2018 Jun;8(1):010803. doi: 10.7189/jogh.08.010803. J Glob Health. 2018. PMID: 29899983 Free PMC article.
-
Cross-sectional and longitudinal associations between adherence to Mediterranean diet with physical performance and cognitive function in older adults: A systematic review and meta-analysis.Ageing Res Rev. 2021 Sep;70:101395. doi: 10.1016/j.arr.2021.101395. Epub 2021 Jun 19. Ageing Res Rev. 2021. PMID: 34153553
-
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159. Cochrane Database Syst Rev. 2001. PMID: 11687175 Free PMC article.
-
Association Between Diabetic Retinopathy, Brain Structural Abnormalities, and Cognitive Impairment for Accumulated Evidence in Observational Studies.Am J Ophthalmol. 2022 Jul;239:37-53. doi: 10.1016/j.ajo.2022.01.011. Epub 2022 Jan 19. Am J Ophthalmol. 2022. PMID: 35063409
Cited by
-
The Diabetic Cognitive Impairment Score for Early Screening of Cognitive Impairment in Type 2 Diabetes Patients.J Diabetes Res. 2025 Apr 16;2025:8029913. doi: 10.1155/jdr/8029913. eCollection 2025. J Diabetes Res. 2025. PMID: 40271536 Free PMC article.
-
Association Between Hormone Levels and Retinopathy in Patients With Type 2 Diabetes: A Cross-Sectional Study.Transl Vis Sci Technol. 2025 Feb 3;14(2):17. doi: 10.1167/tvst.14.2.17. Transl Vis Sci Technol. 2025. PMID: 39937169 Free PMC article.
-
Cognitive dysfunction in diabetes-related foot complications: A cohort study.J Diabetes Metab Disord. 2024 Jan 22;23(1):1017-1038. doi: 10.1007/s40200-023-01381-4. eCollection 2024 Jun. J Diabetes Metab Disord. 2024. PMID: 38932904 Free PMC article.
-
Value proposition of retinal imaging in Alzheimer's disease screening: A review of eight evolving trends.Prog Retin Eye Res. 2024 Nov;103:101290. doi: 10.1016/j.preteyeres.2024.101290. Epub 2024 Aug 22. Prog Retin Eye Res. 2024. PMID: 39173942 Free PMC article. Review.
References
-
- World Health Organization. Dementia [electronic resource]: a public health priority. Geneva: World Health Organization; 2012.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical